Partnership reflects a bigger shift: medical wea

New findings suggest investigational therapy may

New peptide reviews aim to bring structure and t

Company introduces BASE, its lowest-priced membe

Biomarker results suggest PrimeC may be acting o

UCL and Eisai have signed a new agreement extendi

NkGen Biotech will present Troculeucel, its cryop

Elixirgen Therapeutics has expanded its rare dise

NorthStrive Biosciences, a subsidiary of PMGC Hol

MED-EL has acquired two gene therapy programs fro

Insilico Medicine announced a strategic collabora

FDA RDEP eligibility for REP-0003 in HoFH streng

Vasily Yurenkov, founder and CEO of Greener Relo

Prema Cognition and Phoenix Community launch one

A new in vivo program could help bring regenerat

METiS TechBio has granted Boulevard Bio an exclus

Cumulus Neuroscience announced publication of CNS

AlzeCure has entered an out-licensing and collabo

Protagenic Therapeutics published preclinical dat

Sana will present clinical data from an investiga

A peer-reviewed study published in Scientific Rep

Swiss longevity biotech meets luxury skincare as

Following a successful inaugural event in London

SystemAge 2.

Oligomerix secures $1.

Chinese biotech wins US approval to test an off-

Eisai will present more than 50 Alzheimer’s dis

Voyager Therapeutics will present a Developing To

Genflow Biosciences reported that shareholders ap

Gannet BioChem and Serina Therapeutics have enter

Designs for Health launches gut-focused probioti

Theravance deal gives biotech firm a marketed me

AI-driven discovery, precision medicine, transla

AlzLabs collaboration comes as Aptorum and Diami

Startup’s ‘escape artist’ approach could h

NeuroSense announced that its Phase 2b PARADIGM s

Insilico Medicine has promoted its Pharma.

United Therapeutics announced that the U.S.

4DMT has completed global enrollment for 4FRONT-2

Boston biotech secures Series A funding to move

Former Verge Genomics is building AI models from

15,000-woman waitlist suggests demand for precis

FDA Breakthrough Therapy Designation for fosigot

New evidence suggests one overlooked saturated f

NeuroSense reported positive biomarker findings f

Generation Lab announced the general availability

VeriSIM Life has entered into a Material Transfer

LyGenesis received a research award from Breakthr

Parallel Health has joined the Blue Shield of Cal

New funding will help advance two one-time CRISP